Nevro Corp Announces Issuance of Key U.S. Patents for Innovative Chronic Pain Treatment
6/27/2012 9:52:51 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company’s Senza™ High-Frequency Spinal Cord Stimulation System. U.S. Patent No. 8,170,675 includes multiple claims directed to methods for delivering pulsed electrical signals to the epidural space of the spinal cord at frequencies between about 1.5 kHz and about 50 kHz to relieve a patient’s chronic leg and/or back pain without creating paresthesia. Paresthesia is typically a tingling, buzzing sensation associated with conventional low-frequency spinal cord stimulation systems that patients often find unpleasant.